| Aaron L Greeley, DO | |
|
5605 W Eugie Ave Ste 110, Glendale, AZ 85304-1273 | |
| (623) 847-2000 | |
| Not Available |
| Full Name | Aaron L Greeley |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 5605 W Eugie Ave Ste 110, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225096464 | NPI | - | NPPES |
| 231743 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 4562 (Arizona) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 4562 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Thunderbird Medical Center | Glendale, AZ | Hospital |
| Banner Estrella Medical Center | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Imaging Services Llc | 1850724386 | 90 |
| Sonoran Radiology Ltd | 3375964505 | 367 |
| Associated Valley Radiologists Ltd | 8325388499 | 41 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Southwest Diagnostic Imaging Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902896236 PECOS PAC ID: 7416946199 Enrollment ID: O20040507001294 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Page Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1578515789 PECOS PAC ID: 5496665861 Enrollment ID: O20110328000098 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Banner Hospital Based Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Associated Valley Radiologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932683257 PECOS PAC ID: 8325388499 Enrollment ID: O20190327003225 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Banner Imaging Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770139958 PECOS PAC ID: 1850724386 Enrollment ID: O20191213001312 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Sonoran Radiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200526002412 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Toca At Banner Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386270932 PECOS PAC ID: 3072934777 Enrollment ID: O20200604003160 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron L Greeley, DO 2323 W Rose Garden Ln, Phoenix, AZ 85027-2530 Ph: (623) 931-7999 | Aaron L Greeley, DO 5605 W Eugie Ave Ste 110, Glendale, AZ 85304-1273 Ph: (623) 847-2000 |
News Archive
The slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias, according to an article in the September issue of Archives of Neurology.
Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.
The David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
Dr. Perry S Hiscok, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7111 W Bell Rd, Suite 104, Glendale, AZ 85308 Phone: 623-533-4465 | |
Dr. Murali G Murty, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5810 W Beverly Ln, Glendale, AZ 85306 Phone: 623-312-3000 Fax: 623-312-3060 | |
Dr. Abhinav P Patel, MD Radiology Medicare: Medicare Enrolled Practice Location: 5555 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-865-5555 | |
Phillip M Moeser, MD Radiology Medicare: Medicare Enrolled Practice Location: 5322 W Northern Ave, Southwest Diagnostic Imaging Ltd, Glendale, AZ 85301 Phone: 480-425-5063 Fax: 623-915-6924 | |
Denise J Smith, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5605 W Eugie Ave Ste 110, Glendale, AZ 85304 Phone: 623-847-2000 | |
Patrick R Miller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5810 W Beverly Ln, Glendale, AZ 85306 Phone: 623-312-3000 Fax: 623-312-3060 | |
Dr. Raul Galvez-trevino, M.D., M.P.H. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5605 W Eugie Ave Ste 110, Glendale, AZ 85304 Phone: 623-847-2000 |